BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29141888)

  • 21. Origin and production of inflammatory perivascular macrophages in pulmonary hypertension.
    Florentin J; Dutta P
    Cytokine; 2017 Dec; 100():11-15. PubMed ID: 28855075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice.
    Pradhan K; Sydykov A; Tian X; Mamazhakypov A; Neupane B; Luitel H; Weissmann N; Seeger W; Grimminger F; Kretschmer A; Stasch JP; Ghofrani HA; Schermuly RT
    Int J Cardiol; 2016 Aug; 216():85-91. PubMed ID: 27140341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of cGMP phosphodiesterase 5 suppresses matrix metalloproteinase-2 production in pulmonary artery smooth muscles cells.
    Sun XZ; Li ZF; Liu Y; Fang P; Li MX
    Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):362-7. PubMed ID: 19793106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Time- and Compartment-Specific Activation of Lung Macrophages in Hypoxic Pulmonary Hypertension.
    Pugliese SC; Kumar S; Janssen WJ; Graham BB; Frid MG; Riddle SR; El Kasmi KC; Stenmark KR
    J Immunol; 2017 Jun; 198(12):4802-4812. PubMed ID: 28500078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased numbers of T-lymphocytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmonary hypertension secondary to congenital cardiac shunts.
    Pinto RF; Higuchi Mde L; Aiello VD
    Cardiovasc Pathol; 2004; 13(5):268-75. PubMed ID: 15358341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury.
    Ladha F; Bonnet S; Eaton F; Hashimoto K; Korbutt G; Thébaud B
    Am J Respir Crit Care Med; 2005 Sep; 172(6):750-6. PubMed ID: 15947285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vardenafil reduces macrophage pro-inflammatory overresponses in cystic fibrosis through PDE5- and CFTR-dependent mechanisms.
    Noel S; Panin N; Beka M; Dhooghe B; Huaux F; Leal T
    Clin Sci (Lond); 2017 Jun; 131(11):1107-1121. PubMed ID: 28196856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling.
    Taraseviciene-Stewart L; Nicolls MR; Kraskauskas D; Scerbavicius R; Burns N; Cool C; Wood K; Parr JE; Boackle SA; Voelkel NF
    Am J Respir Crit Care Med; 2007 Jun; 175(12):1280-9. PubMed ID: 17413127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension.
    Berghausen EM; Feik L; Zierden M; Vantler M; Rosenkranz S
    Herz; 2019 Apr; 44(2):130-137. PubMed ID: 30847510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NF-κB mediated miR-130a modulation in lung microvascular cell remodeling: Implication in pulmonary hypertension.
    Li L; Kim IK; Chiasson V; Chatterjee P; Gupta S
    Exp Cell Res; 2017 Oct; 359(1):235-242. PubMed ID: 28755990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats.
    Sawada H; Mitani Y; Maruyama J; Jiang BH; Ikeyama Y; Dida FA; Yamamoto H; Imanaka-Yoshida K; Shimpo H; Mizoguchi A; Maruyama K; Komada Y
    Chest; 2007 Oct; 132(4):1265-74. PubMed ID: 17934115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular Cyclophilin A, Especially Acetylated, Causes Pulmonary Hypertension by Stimulating Endothelial Apoptosis, Redox Stress, and Inflammation.
    Xue C; Sowden M; Berk BC
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1138-1146. PubMed ID: 28450293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
    Ghofrani HA; Voswinckel R; Reichenberger F; Olschewski H; Haredza P; Karadaş B; Schermuly RT; Weissmann N; Seeger W; Grimminger F
    J Am Coll Cardiol; 2004 Oct; 44(7):1488-96. PubMed ID: 15464333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis.
    Avouac J; Guignabert C; Hoffmann-Vold AM; Ruiz B; Dorfmuller P; Pezet S; Amar O; Tu L; Van Wassenhove J; Sadoine J; Launay D; Elhai M; Cauvet A; Subramaniam A; Resnick R; Hachulla E; Molberg Ø; Kahan A; Humbert M; Allanore Y
    Arthritis Rheumatol; 2017 Nov; 69(11):2209-2221. PubMed ID: 28805015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tadalafil induces antiproliferation, apoptosis, and phosphodiesterase type 5 downregulation in idiopathic pulmonary arterial hypertension in vitro.
    Yamamura A; Fujitomi E; Ohara N; Tsukamoto K; Sato M; Yamamura H
    Eur J Pharmacol; 2017 Sep; 810():44-50. PubMed ID: 28603047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lewis Lung Cancer Cells Promote SIGNR1(CD209b)-Mediated Macrophages Polarization Induced by IL-4 to Facilitate Immune Evasion.
    Yan X; Li W; Pan L; Fu E; Xie Y; Chen M; Mu D
    J Cell Biochem; 2016 May; 117(5):1158-66. PubMed ID: 26447454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salusin-β contributes to vascular inflammation associated with pulmonary arterial hypertension in rats.
    Xu T; Zhang Z; Liu T; Zhang W; Liu J; Wang W; Wang J
    J Thorac Cardiovasc Surg; 2016 Oct; 152(4):1177-87. PubMed ID: 27353339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation, immunological reaction and role of infection in pulmonary hypertension.
    Pullamsetti SS; Savai R; Janssen W; Dahal BK; Seeger W; Grimminger F; Ghofrani HA; Weissmann N; Schermuly RT
    Clin Microbiol Infect; 2011 Jan; 17(1):7-14. PubMed ID: 20545963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nur77 downregulation triggers pulmonary artery smooth muscle cell proliferation and migration in mice with hypoxic pulmonary hypertension via the Axin2-β-catenin signaling pathway.
    Nie X; Tan J; Dai Y; Mao W; Chen Y; Qin G; Li G; Shen C; Zhao J; Chen J
    Vascul Pharmacol; 2016 Dec; 87():230-241. PubMed ID: 27871853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.